News
The US Food and Drug Administration (FDA) on Wednesday approved Gilead Sciences lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and adolescents at high risk of ...
The United States Food and Drug Administration, FDA, has approved a new long-acting injectable drug, Lenacapavir, for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback